RHHVF Stock: Roche Holding AG Stock Price, Analysis & Insights
Get live RHHVF stock price $411.25, comprehensive Roche Holding AG stock analysis, charts, news, and expert forecast. Real-time RHHVF stock data and investment insights.
Loading chart data...
Roche Holding AG (RHHVF) Overview
Roche Holding AG (RHHVF) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - General industry . As of the latest trading session, RHHVF trades at $411.25 with a market capitalization of 327.35B . Over the past 52 weeks, RHHVF has traded between $277.00 and $490.33 , with the current price positioned at approximately 63% of this range . The stock ...
Key Takeaways
- Operates in the Healthcare sector (Drug Manufacturers - General)
- Market cap: 327.35B
- Current price: $411.25
- 52-week range: $277.00 - $490.33
- P/E ratio: 20.21
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Roche Holding AG operates as a global healthcare leader, specializing in both pharmaceuticals and diagnostics. The company's reach extends across key markets like Switzerland, Germany, and the United States, in addition to its broader international f...
Company Information
- CEO
- Thomas Schinecker
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Employees
- 103249
Contact Information
- Website
- https://www.roche.com
- Address
- Grenzacherstrasse 124
- Country
- CH
Investment Analysis & Business Insights
Investment Highlights
✓ Market leader with 327.4 billion market capitalization
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 20.2)
✓ Lower volatility stock (Beta: 0.33) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Roche Holding AG shareholders
- ⚠Market volatility can significantly impact stock price, especially for large-cap equities
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Roche Holding AG
- ⚠Investors should consider how Roche Holding AG fits within their overall portfolio allocation
Market Cap
327.35B
P/E Ratio (TTM)
20.21
Beta
0.33
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare RHHVF with peer companies:
- Price
- $13.25-8.51% (1D)
- Market cap
- 23.74B
- Price
- $178.96-2.44% (1D)
- Market cap
- 277.54B
- Price
- $189.90+0.00% (1D)
- Market cap
- 294.40B
- Price
- $10.16-0.29% (1D)
- Market cap
- 39.93B
- Price
- $55.60-1.56% (1D)
- Market cap
- 113.54B
- Price
- $400.00+0.00% (1D)
- Market cap
- 814.59B
- Price
- $7.32-0.27% (1D)
- Market cap
- 6.19B
- Price
- $51.17-0.16% (1D)
- Market cap
- 102.57B
- Price
- $148.12-0.67% (1D)
- Market cap
- 282.63B
- Price
- $144.88+0.00% (1D)
- Market cap
- 276.44B
- Price
- $414.00+1.22% (1D)
- Market cap
- 329.54B
- Price
- $50.42+0.56% (1D)
- Market cap
- 324.75B
- Price
- $0.16+17.73% (1D)
- Market cap
- 1.36M
- Price
- $43.57-2.59% (1D)
- Market cap
- 104.75B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
60/100 ⭐⭐⭐⭐
- Overall
- -1.4%
- NYSE
- -0.6%
- NASDAQ
- -2.2%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | +0.2% | +1.6% | +1.7% | 19.1 | 100/100⭐⭐⭐⭐⭐ |
| Communication Services | -0.2% | -1.8% | +1.2% | 21.9 | 83/100⭐⭐⭐⭐⭐ |
| Energy | -0.2% | -6.1% | +1.5% | 37.0 | 75/100⭐⭐⭐⭐⭐ |
| Healthcare | -1.4% | -3.7% | -0.5% | 30.2 | 60/100⭐⭐⭐⭐ |
| Technology | -0.8% | -7.7% | +0.0% | 48.7 | 55/100⭐⭐⭐⭐ |
| Consumer Defensive | +0.7% | +3.0% | -1.6% | 31.1 | 50/100⭐⭐⭐ |
| Real Estate | -1.0% | -1.8% | -1.9% | 50.3 | 31/100⭐⭐ |
| Industrials | -2.7% | -7.6% | -2.1% | 41.5 | 30/100⭐⭐ |
| Basic Materials | -1.9% | -6.0% | -3.5% | 26.6 | 28/100⭐⭐ |
| Utilities | -2.1% | -6.9% | -8.5% | 25.3 | 24/100⭐ |
| Consumer Cyclical | -1.5% | -4.5% | -3.4% | 52.2 | 14/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score: 70% 1M momentum percentile + 30% valuation percentile (lower P/E ranks higher), shown as 0–100 with stars. Data as of 2026-06-11.